NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Severe scabies is a strong marker for HTLV-I co-infection, in AIDS patients.

Brites C, Pedroso C, Amaral V, Pedral-Sampaio DB, Harrington WJ, Bina JC, Silva N, Badaro R; Conference on Retroviruses and Opportunistic Infections.

Program Abstr 4th Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 4th 1997 Wash DC. 1997 Jan 22-26; 4th: 99 (abstract no. 186a).

Federal University of Bahia-Salvador, Bahia, Brazil.

Objective: To evaluate the frequency of HTLV-I co-infection among AIDS patients presenting severe scabies. Patients and methods: We tested all AIDS patients admitted to the Infectious Diseases Unit (IDU) of University with a diagnosis of severe scabies, for HTLV-I antibodies, using an EIA kit (Coulter Corp, FL). The positive samples were confirmed by Western blot (Cellular Products, NY). We compared the prevalence of HTLV-I antibodies in this group with the frequency of HTLV-I infection in a large cohoort of HIV-1 infected subjects. Results: The IDU cares an average of 250 AIDS in patients/year. From May 1994 through November, 1995, the IDU admitted to AIDS patients (7 men) presenting severe, disseminated scabies. The 10 patients were positive for HTLV-I , while the prevalence of HTLV-I co-infection among 895 individuals previously tested was only 11.4% (p is less than 0.000001, Yates corrected). All patients with severe scabies had a history of intravenous drug use (IVDU). There was an association between IVDU and scabies (among the 895 subjects 19.2% were IVDU, and 33.7% of them had HTLV-I co-infection, against 100% of scabies patients (p=0.00005). Conclusions: Severe scabies among AIDS patients was a strong predictor for HTLV-I co-infection, in Bahia, Brazil. Also, we detected a significantly higher frequency of IVDU in this group, compared with a larger sample of HIV-HTLV-I co-infected patients.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Blotting, Western
  • Brazil
  • HIV
  • HIV Antibodies
  • HIV Infections
  • HIV Seropositivity
  • HIV Seroprevalence
  • HIV-1
  • HTLV-I Antibodies
  • HTLV-I Infections
  • Human T-lymphotropic virus 1
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Prevalence
  • Scabies
  • Substance Abuse, Intravenous
Other ID:
  • 97926837
UI: 102225364

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov